Bansisons Tea Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2026 ,inter alia, to consider and approve Audited Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The company has postponed its Board meeting originally scheduled for April 29, 2026. The meeting has been rescheduled to May 2, 2026 to consider and approve the Audited Financial Results along with the Auditor's Report and Certificate for unmodified opinion for the quarter and year ended March 31, 2026. The company also clarified its name change from Bansisons Tea Industries Ltd to Novyra Pharmachem Limited. This is a routine procedural filing informing investors about the meeting reschedule.
Minimal direct impact on shareholders - this is an administrative reschedule. The key positive signal is the auditors' intent to issue an unmodified (clean) opinion on the financial statements, which indicates no material concerns with the company's financial reporting.